SARS-CoV-2 XEC: A Genome-Based Survey

Area of Science:

• Virology
• Genomics
• Molecular Biology

Background:

• Recombination is a key driver in the evolution of SARS-CoV-2 variants.
• The emergence of novel recombinant lineages necessitates detailed genomic and structural characterization.

Purpose of the Study:

• To perform a comprehensive genomic and structural analysis of the SARS-CoV-2 XEC recombinant.
• To understand the evolutionary trajectory and public health implications of XEC.

Main Methods:

• Phylogenomic analyses to determine evolutionary relationships.
• Identification of genomic breakpoints and mutational analysis.
• Bayesian Skyline Plot analysis for population dynamics.

Main Results:

• XEC is a recombinant of KP.3.3 and KS.1.1, with a breakpoint in the spike protein gene.
• Mutations in XEC are associated with immune evasion and receptor binding, but lack novel changes in conserved epitopes.
• XEC exhibits limited geographical spread, low genetic variability, and a stable but declining population size, suggesting an evolutionary dead-end.

Conclusions:

• XEC, while possessing some immune-evasive mutations, is unlikely to become a significant public health threat.
• Ongoing genomic surveillance is crucial for monitoring the emergence and characteristics of viral recombinants.
• Distinguishing between variants of concern and those with limited epidemiological impact is vital.